一大早就看到了这个公告。总体而言，销售增长很多，尤其是中国市场，相对于BKL增长慢了，但是，长期看好VITACO！
评论
Loss is most due to the one-off integration cost of Musashi brand.Compare to BKL, VIT's PE is way lower. Solid performance I would say, this company got potential, considering it's paying maiden dividend as well.
评论
对的。亏损的一部分在于一次性IPO花费。关键是看到了VIT增长，特别是中国那块目前还很小的比例，潜力比BKL好多了。另外，VIT的产品分配还蛮均衡，长期看是个利好。
评论
很有煽动性的标题！
你怎么不写中国市场增长233％ ？
评论
不知道市场如何反应
评论
very very very bad report.
NPAT increase is way off the expectation even without one-off expenses.
评论
中国市场挺好的啊，而且没想到在中国销量还可以。 业绩总体确实不及市场预期，和IPO预期相同。。。
评论
Which expectation are you referring to? It doesn't seem that far off from expectation. See the following:
Full Year VIT IPO forecast $23.7m Pro Forma EBITDA and Morgans forecast Pro Forma EBITDA is $24.7M, currently Pro-forma EBITDA is $10.4m for 1st HY 2016, and it has reaffirmed the company is on track to meet IPO profit forecast.
评论
市场预期比IPO的要高，明天你看黑多多的半年报吧
评论
Morgans latest (24-02-2016):
Vitaco (VIT)
NPAT: A$5.6 million; Dividend: 1.69cps
The result was above expectations.
Morgans comment
Solid 1H16 result which beat our forecast. The Vitamins and Supplements result was the highlight (EBIT +77% on pcp). Stronger than expected China sales, albeit off a low base. Full year guidance is maintained. Musashi acquisition is on track.
抱歉， 没有权限发链接。
评论
看好中国业务发展
评论
Buy it at your will please.
评论
确实很一般，看下半年了，现在PE都和BKL差不多了但是BKL增长快多了
优势就是比起BKL Revenue和市值还是很小的，增长潜力更大
评论
几乎没买票，都在疯狂割肉
评论
什么情况。。。跌成这样 我已经赔惨了
评论
这个Morgans是什么货？
澳洲中文论坛热点
- 悉尼部份城铁将封闭一年，华人区受影响！只能乘巴士（组图）
- 据《逐日电讯报》报导，从明年年中开始，因为从Bankstown和Sydenham的城铁将因Metro South West革新名目而
- 联邦政客们具有多少房产？
- 据本月早些时分报导，绿党副首领、参议员Mehreen Faruqi已获准在Port Macquarie联系其房产并建造三栋投资联